MPO and gout: Seventeen potential MPO inhibitors werechosen and tested in a comprehensive pipeline, which includes enzymaticand cellular experiments as well as a murine model of gouty arthritis.In line with the methodology’s robustness, more than 60% ofthe selected compounds inhibited the MPO chlorinating and peroxidaticactivities.